LFCR
Price
$6.54
Change
+$0.01 (+0.15%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
247.34M
35 days until earnings call
Intraday BUY SELL Signals
TLRY
Price
$3.60
Change
+$0.04 (+1.12%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
564.5M
Intraday BUY SELL Signals
Interact to see
Advertisement

LFCR vs TLRY

LFCR vs TLRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LFCR vs. TLRY commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Buy and TLRY is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
LFCR vs TLRY: Fundamental Ratings
LFCR
TLRY
OUTLOOK RATING
1..100
4259
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
3587
P/E GROWTH RATING
1..100
590
SEASONALITY SCORE
1..100
2650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (38) in the Biotechnology industry is somewhat better than the same rating for LFCR (90) in the Industrial Specialties industry. This means that TLRY’s stock grew somewhat faster than LFCR’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

TLRY's SMR Rating (92) in the Biotechnology industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that TLRY’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (35) in the Industrial Specialties industry is somewhat better than the same rating for TLRY (87) in the Biotechnology industry. This means that LFCR’s stock grew somewhat faster than TLRY’s over the last 12 months.

LFCR's P/E Growth Rating (5) in the Industrial Specialties industry is significantly better than the same rating for TLRY (90) in the Biotechnology industry. This means that LFCR’s stock grew significantly faster than TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRTLRY
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (LFCR: $6.53 vs. TLRY: $3.57)
Brand notoriety: LFCR: Not notable vs. TLRY: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 282% vs. TLRY: 182%
Market capitalization -- LFCR: $247.34M vs. TLRY: $564.5M
LFCR [@Pharmaceuticals: Generic] is valued at $247.34M. TLRY’s [@Pharmaceuticals: Generic] market capitalization is $564.5M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green while TLRY’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, LFCR is a better buy in the long-term than TLRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 5 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • LFCR’s TA Score: 5 bullish, 5 bearish.
  • TLRY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than TLRY.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а +52.21% price change this week, while TLRY (@Pharmaceuticals: Generic) price change was -12.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.71%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +29.84%.

Reported Earning Dates

LFCR is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.71% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
LFCR
Daily Signal:
Gain/Loss:
TLRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DFAS77.980.56
+0.72%
Dimensional U.S. Small Cap ETF (DFAS)
BRKW37.970.14
+0.37%
Roundhill BRKB WeeklyPay ETF (BRKW)
QQMG51.990.15
+0.30%
Invesco ESG NASDAQ 100 ETF (QQMG)
BSJQ22.82-0.01
-0.02%
Invesco BulletShares 2026 High Yield Corp Bond ETF (BSJQ)
EFAS21.37-0.41
-1.86%
Global X MSCI SuperDividend EAFE ETF (EFAS)

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-0.76%
SHPH - LFCR
31%
Poorly correlated
-0.74%
COLL - LFCR
28%
Poorly correlated
+0.09%
PAHC - LFCR
27%
Poorly correlated
+0.36%
TLRY - LFCR
27%
Poorly correlated
-4.80%
VTRS - LFCR
25%
Poorly correlated
-1.47%
More

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
-4.80%
SNDL - TLRY
76%
Closely correlated
-2.33%
CGC - TLRY
75%
Closely correlated
-1.54%
ACB - TLRY
73%
Closely correlated
N/A
CRON - TLRY
64%
Loosely correlated
-2.73%
GLAS - TLRY
59%
Loosely correlated
-5.17%
More